Patent ID: 8722083

Claim:
A dosage form comprising a therapeutically effective amount of fenofibric acid, pharmaceutically acceptable salts thereof, pharmaceutically acceptable esters thereof, or prodrugs thereof, said dosage form comprising: a plurality of first granules and a plurality of second granules being combined in a weight ratio of said first granules to said second granules of between about 50:50 and about 90:10, wherein said dosage form provides a peak plasma concentration of fenofibric acid of between 4000 ng/mL and 4800 ng/mL when administered to a human subject; wherein a first comparative dosage form comprising 100% of first granules provides a peak plasma concentration of fenofibric acid of greater than 4800 ng/mL when administered to said human subject; and a second comparative dosage form comprising 100% of second granules provides a peak plasma concentration of fenofibric acid of less than 3500 ng/mL when administered to said human subject.